FindTrial
Sign In

Research on CT Evaluation of the Efficacy of Neoadjuvant Therapy for Esophageal Cancer

CT Radiomics Model for Predicting the Efficacy of Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112090
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Observation group:None

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients have undergone standardized preoperative neoadjuvant therapy (including radiotherapy, chemotherapy, and immunotherapy) and surgical treatment. The diagnosis and treatment have undergone; 2.pathological specimen refinement to accurately determine whether pCR is present; 3. Having complete dual period (pre-treatment and neoadjuvant therapy) MSCT plain and enhanced scan images.

Exclusion criteria

Exclusion criteria: 1.The patient did not receive standardized treatment or did not receive standardized treatment for various reasons; 2. The CT image quality is poor or there are artifacts, which cannot meet the diagnostic requirements and calibration analysis.

Design outcomes

Primary

MeasureTime frame
Pathologic complete response;—

Countries

China

Contacts

Public ContactGe Song

Zhejiang Cancer Hospital

applesong1985@sina.com+86 571 8812 2348

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026